Encompass Health Q2 2025 Results: Net Revenue Rises 12%, EPS Up by 26.1%

Reuters
Aug 05, 2025
Encompass Health <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results: Net Revenue Rises 12%, EPS Up by 26.1%

Encompass Health Corporation, the largest owner and operator of inpatient rehabilitation hospitals in the United States, has reported its financial results for the second quarter of 2025. The company achieved a net operating revenue of $1.4577 billion, marking a 12.0% increase from $1.3012 billion in the same period of the previous year. This growth was driven by an increase in discharges and pricing, with total discharges rising by 7.2% and net patient revenue per discharge increasing by 4.2%. Income from continuing operations attributable to Encompass Health per diluted share rose to $1.40, up from $1.13, representing a 23.9% increase. Adjusted earnings per share also climbed by 26.1%, reaching $1.40 from $1.11. Additionally, cash flows provided by operating activities increased to $270.2 million, a 24.3% rise from $217.4 million in Q2 2024. Encompass Health has also updated its full-year 2025 guidance. The company now expects net operating revenue to range between $5.880 billion and $5.980 billion, revised from the previous guidance of $5.850 billion to $5.925 billion. Adjusted EBITDA is projected to be between $1.220 billion and $1.250 billion, and adjusted earnings per share from continuing operations are anticipated to be between $5.12 and $5.34.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL43704) on August 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10